GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,291,796 | -16.6% | 106,582 | 0.0% | 0.07% | -13.4% |
| Q2 2023 | $6,345,892 | +5.1% | 106,582 | 0.0% | 0.08% | +9.3% |
| Q1 2023 | $6,036,804 | -23.7% | 106,582 | 0.0% | 0.08% | -35.3% |
| Q4 2022 | $7,915,845 | +24.7% | 106,582 | 0.0% | 0.12% | +13.7% |
| Q3 2022 | $6,349,000 | +6.1% | 106,582 | 0.0% | 0.10% | +13.3% |
| Q2 2022 | $5,984,000 | -26.2% | 106,582 | 0.0% | 0.09% | -18.2% |
| Q1 2022 | $8,105,000 | -10.2% | 106,582 | -14.4% | 0.11% | -8.3% |
| Q4 2021 | $9,028,000 | +557.5% | 124,507 | +594.6% | 0.12% | +445.5% |
| Q3 2021 | $1,373,000 | -1.2% | 17,925 | 0.0% | 0.02% | -12.0% |
| Q2 2021 | $1,390,000 | +25.8% | 17,925 | 0.0% | 0.02% | +13.6% |
| Q1 2021 | $1,105,000 | -21.2% | 17,925 | -16.6% | 0.02% | -33.3% |
| Q4 2020 | $1,402,000 | +31.8% | 21,500 | 0.0% | 0.03% | +6.5% |
| Q3 2020 | $1,064,000 | – | 21,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |